Teladoc Weight Management, Telehealth Platform

Teladoc Health's weight management program is offered through one of the largest and most established telehealth platforms in the US, integrated into thousands of employer benefit programs. This means many patients can access Teladoc's weight loss services at reduced or zero cost if their employer includes it in their benefits package. The program offers GLP-1 prescriptions alongside nutritional counseling and ongoing provider support in 11 states through its specialized weight management track. Where Teladoc differs from dedicated GLP-1 startups is infrastructure and insurance access — the platform accepts five major insurance carriers and has the broadest payer relationships of any telehealth weight loss option. The tradeoff is specialization: Teladoc handles weight management as one vertical among many (general medicine, dermatology, mental health), so the clinical depth around GLP-1 dosing and metabolic optimization may not match platforms that focus exclusively on obesity medicine. For patients with employer-sponsored Teladoc access or strong insurance coverage, this is potentially the most affordable pathway to GLP-1 treatment. For uninsured patients, dedicated cash-pay platforms will likely offer better pricing. package. The program offers GLP-1 prescriptions alongside nutritional counseling and ongoing provider support in 11 states through its specialized weight management track. Where Teladoc differs from dedicated GLP-1 startups is infrastructure and insurance access — the platform accepts five major insurance carriers and has the broadest payer relationships of any telehealth weight loss option. The tradeoff is specialization: Teladoc handles weight management as one vertical among many (general medicine, dermatology, mental health), so the clinical depth around GLP-1 dosing and metabolic optimization may not match platforms that focus exclusively on obesity medicine. For patients with employer-sponsored Teladoc access or strong insurance coverage, this is potentially the most affordable pathway to GLP-1 treatment. For uninsured patients, dedicated cash-pay platforms will likely offer better pricing.